Search Results 51-60 of 18969 for alzheimers
Lecanemab (Leqembi) is a medicine given to slow the progression of mild Alzheimer's disease (AD). This medicine reduces clumps of proteins called amyloid ...
The Alzheimer's Association convened the work group as new clinical data are expected soon from several studies of emerging therapeutics. Interpretation of ...
As an Alzheimer's caregiver, you might be your loved one's most powerful voice. Make decisions that ensure dignity and comfort for your loved one.
Providing care for someone who has Alzheimer's disease can be physically and emotionally hard. It often takes a great deal of patience, compassion and ...
Alzheimer's disease is a progressive disease that destroys memory and other important mental functions. Many people who have relatives with this disease ...
Lewy body dementia, also known as LBD, is the second most common type of dementia after Alzheimer's disease. Protein deposits called Lewy bodies develop in ...
It can often be mistaken for Alzheimer's disease. The good news: Limbic-predominant Amnestic Neurodegenerative Syndrome, or LANS, progresses more slowly and has ...
Wandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen in the early ...
They're approved for people with mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease. Clinical trials found that the medicines ...
Contact the Alzheimer's Disease Research Center at Mayo Clinic in Rochester, Minnesota, or Jacksonville, Florida.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.